|
PMID |
|
|
TITLE |
|
The effect of polygenic liability to mental disorders on COVID-19 outcomes in people with depression: the mediating role of anxiety. |
|
ABSTRACT |
|
BACKGROUND |
NlmCategory: BACKGROUND |
Genetic vulnerability to mental disorders has been associated with coronavirus disease-19 (COVID-19) outcomes. We explored whether polygenic risk scores (PRSs) for several mental disorders predicted poorer clinical and psychological COVID-19 outcomes in people with pre-existing depression. |
METHODS |
NlmCategory: METHODS |
Genetic vulnerability to mental disorders has been associated with coronavirus disease-19 (COVID-19) outcomes. We explored whether polygenic risk scores (PRSs) for several mental disorders predicted poorer clinical and psychological COVID-19 outcomes in people with pre-existing depression. Data from three assessments of the Australian Genetics of Depression Study ( = 4405; 52.2 years ± 14.9; 76.2% females) were analyzed. Outcomes included COVID-19 clinical outcomes (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection and long COVID, noting the low incidence of COVID-19 cases in Australia at that time) and COVID-19 psychological outcomes (COVID-related stress and COVID-19 burnout). Predictors included PRS for depression, bipolar disorder, schizophrenia, and anxiety. The associations between these PRSs and the outcomes were assessed with adjusted linear/logistic/multinomial regressions. Mediation ( = 4338) and moderation ( = 3326) analyses were performed to explore the potential influence of anxiety symptoms and resilience on the identified associations between the PRSs and COVID-19 psychological outcomes. |
RESULTS |
NlmCategory: RESULTS |
Genetic vulnerability to mental disorders has been associated with coronavirus disease-19 (COVID-19) outcomes. We explored whether polygenic risk scores (PRSs) for several mental disorders predicted poorer clinical and psychological COVID-19 outcomes in people with pre-existing depression. Data from three assessments of the Australian Genetics of Depression Study ( = 4405; 52.2 years ± 14.9; 76.2% females) were analyzed. Outcomes included COVID-19 clinical outcomes (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection and long COVID, noting the low incidence of COVID-19 cases in Australia at that time) and COVID-19 psychological outcomes (COVID-related stress and COVID-19 burnout). Predictors included PRS for depression, bipolar disorder, schizophrenia, and anxiety. The associations between these PRSs and the outcomes were assessed with adjusted linear/logistic/multinomial regressions. Mediation ( = 4338) and moderation ( = 3326) analyses were performed to explore the potential influence of anxiety symptoms and resilience on the identified associations between the PRSs and COVID-19 psychological outcomes. None of the selected PRS predicted SARS-CoV-2 infection or long COVID. In contrast, the depression PRS predicted higher levels of COVID-19 burnout. Anxiety symptoms fully mediated the association between the depression PRS and COVID-19 burnout. Resilience did not moderate this association. |
CONCLUSIONS |
NlmCategory: CONCLUSIONS |
Genetic vulnerability to mental disorders has been associated with coronavirus disease-19 (COVID-19) outcomes. We explored whether polygenic risk scores (PRSs) for several mental disorders predicted poorer clinical and psychological COVID-19 outcomes in people with pre-existing depression. Data from three assessments of the Australian Genetics of Depression Study ( = 4405; 52.2 years ± 14.9; 76.2% females) were analyzed. Outcomes included COVID-19 clinical outcomes (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection and long COVID, noting the low incidence of COVID-19 cases in Australia at that time) and COVID-19 psychological outcomes (COVID-related stress and COVID-19 burnout). Predictors included PRS for depression, bipolar disorder, schizophrenia, and anxiety. The associations between these PRSs and the outcomes were assessed with adjusted linear/logistic/multinomial regressions. Mediation ( = 4338) and moderation ( = 3326) analyses were performed to explore the potential influence of anxiety symptoms and resilience on the identified associations between the PRSs and COVID-19 psychological outcomes. None of the selected PRS predicted SARS-CoV-2 infection or long COVID. In contrast, the depression PRS predicted higher levels of COVID-19 burnout. Anxiety symptoms fully mediated the association between the depression PRS and COVID-19 burnout. Resilience did not moderate this association. A higher genetic risk for depression predicted higher COVID-19 burnout and this association was fully mediated by anxiety symptoms. Interventions targeting anxiety symptoms may be effective in mitigating the psychological effects of a pandemic among people with depression. |
|
DATE PUBLISHED |
|
|
HISTORY |
|
PUBSTATUS |
PUBSTATUSDATE |
medline |
2024/11/18 10:19 |
pubmed |
2024/11/18 10:19 |
entrez |
2024/11/18 04:23 |
pmc-release |
2024/12/17 |
|
AUTHORS |
|
NAME |
COLLECTIVENAME |
LASTNAME |
FORENAME |
INITIALS |
AFFILIATION |
AFFILIATIONINFO |
Monistrol-Mula A |
|
Monistrol-Mula |
Anna |
A |
|
Department of Medicine, University of Barcelona, Barcelona, Spain. |
Felez-Nobrega M |
|
Felez-Nobrega |
Mireia |
M |
|
Centre for Biomedical Research on Mental Health (CIBERSAM), Madrid, Spain. |
Byrne EM |
|
Byrne |
Enda M |
EM |
|
Child Health Research Centre, The University of Queensland, Brisbane, Australia. |
Lind PA |
|
Lind |
Penelope A |
PA |
|
School of Biomedical Sciences, University of Queensland, Brisbane, Australia. |
Hickie IB |
|
Hickie |
Ian B |
IB |
|
Brain and Mind Centre, The University of Sydney, Sydney, NSW, Australia. |
Martin NG |
|
Martin |
Nicholas G |
NG |
|
Mental Health and Neuroscience Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. |
Medland SE |
|
Medland |
Sarah E |
SE |
|
School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia. |
Colodro-Conde L |
|
Colodro-Conde |
Lucía |
L |
|
School of Psychology, The University of Queensland, Brisbane, QLD, Australia. |
Mitchell BL |
|
Mitchell |
Brittany L |
BL |
|
School of Biomedical Sciences, University of Queensland, Brisbane, Australia. |
|
INVESTIGATORS |
|
|
JOURNAL |
|
VOLUME: 54 |
ISSUE: 15 |
TITLE: Psychological medicine |
ISOABBREVIATION: Psychol Med |
YEAR: 2024 |
MONTH: Nov |
DAY: 18 |
MEDLINEDATE: |
SEASON: |
CITEDMEDIUM: Internet |
ISSN: 1469-8978 |
ISSNTYPE: Electronic |
|
MEDLINE JOURNAL |
|
MEDLINETA: Psychol Med |
COUNTRY: England |
ISSNLINKING: 0033-2917 |
NLMUNIQUEID: 1254142 |
|
PUBLICATION TYPE |
|
PUBLICATIONTYPE TEXT |
Journal Article |
|
COMMENTS AND CORRECTIONS |
|
|
GRANTS |
|
|
GENERAL NOTE |
|
|
KEYWORDS |
|
KEYWORD |
COVID-19 burnout |
COVID-19 outcomes |
SARS-CoV-2 infection |
anxiety symptoms |
depression |
genetic vulnerability |
mediation analysis |
polygenic risk scores (PRS) |
resilience |
|
MESH HEADINGS |
|
|
SUPPLEMENTARY MESH |
|
|
GENE SYMBOLS |
|
|
CHEMICALS |
|
|
OTHER ID's |
|
|
|